Systematic review / meta-analysis / 2024
Taurine supplementation significantly reduced heart rate and blood pressure while improving cardiac function markers in a meta-analysis of RCTs.
A meta-analysis of 20 randomized controlled trials evaluated the effects of taurine on cardiovascular health in 808 participants. Taurine significantly decreased heart rate (WMD: -3.579 bpm, 95% CI: -6.044 to -1.114), systolic blood pressure (WMD: -3.999 mm Hg, 95% CI: -7.293 to -0.706), diastolic blood pressure (WMD: -1.435 mm Hg, 95% CI: -2.484 to -0.386), and NYHA functional class (WMD: -0.403, 95% CI: -0.522 to -0.283). It also significantly increased LVEF (WMD: 4.981%, 95% CI: 1.556 to 8.407). No significant adverse effects were observed compared to controls.
- Study type
- Systematic review and meta-analysis of randomized controlled trials
- Who was studied
- 808 participants across 20 randomized controlled trials
- What was measured
- Heart rate, systolic and diastolic blood pressure, left ventricular ejection fraction (LVEF), and NYHA Functional Classification
THE PAPER
Insights into the cardiovascular benefits of taurine: a systematic review and meta-analysis.
Tzang CC, Lin WC, Lin LH, Lin TY, Chang KV, Wu WT, Özçakar L. Nutr J, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.